ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils

MLA

Xiaonan Qiu, et al. “ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils.” Frontiers in Immunology, vol. 12, Aug. 2021. EBSCOhost, https://doi.org/10.3389/fimmu.2021.714274.

APA

Xiaonan Qiu, Lin Zheng, Xiuting Liu, Dan Hong, Mintong He, Zengqi Tang, Cuicui Tian, Guozhen Tan, Sam Hwang, Zhenrui Shi, & Liangchun Wang. (2021). ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.714274

Chicago

Xiaonan Qiu, Lin Zheng, Xiuting Liu, Dan Hong, Mintong He, Zengqi Tang, Cuicui Tian, et al. 2021. “ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils.” Frontiers in Immunology 12 (August). doi:10.3389/fimmu.2021.714274.